Q and A: about health and research

ME/CFS is often used as a broad diagnostic category, but in some cases underlying medical conditions may remain partially investigated or overlooked.    Commonly associated factors may include viral infections, post-exertional malaise (PEM), postural orthostatic tachycardia syndrome (POTS), fibromyalgia-like pain, immune or vascular abnormalities, neuroinflammation and/or encephalitis, possible glymphatic or lymphatic system dysfunction, and possible syringomyelia. Further research, including head and torso MRI imaging, comprehensive hematological and endocrinological testing, and evaluation of genetic or inherited markers, may help clarify underlying mechanisms and improve diagnostic understanding. At the same time, important conditions such as thyroid disease, adrenal insufficiency, lupus, hemophilia or other bleeding disorders, infections, vasculitis, and other systemic illnesses may not always be fully excluded and can coexist with or contribute to symptoms. The example...

CoQ10 cannot regenerate dead or permanently scarred tissue.  However, it helps protect and support existing cells by enhancing energy production (ATP) and reducing oxidative stress caused by free radicals. By improving mitochondrial function, CoQ10 supports the body's natural repair and healing processes. Key Cellular and Tissue Benefits 1. Cellular Energy Production CoQ10 plays a critical role in the mitochondrial electron transport chain. It helps generate ATP, the primary energy source required for cell growth, division, maintenance, and repair. 2. Antioxidant Protection CoQ10 acts as a powerful antioxidant that neutralizes harmful free radicals. It also helps regenerate other antioxidants, including Vitamins C and E. This protection helps preserve cellular components such as DNA, proteins, and cell membranes from oxidative damage. 3. Tissue Repair and Regeneration Research, including periodontal health studies, suggests that CoQ10 supports fibroblast activity. Fib...

A diagnosis of myalgia was confirmed by UNMH (USA/NM) on 25 May 2016. A preliminary suspicion of Post-Polio Syndrome—later confirmed in the UK on 15 July 2022—had also been overlooked. However, a subsequent neurological evaluation in Germany (September 2020) failed to identify definitive signs of muscle weakness. The German report, detailing a neurophysiological assessment of a 71-year-old female patient, is methodologically robust. The use of repetitive nerve stimulation, nerve conduction studies, and EMG appears technically competent. However, the interpretative aspects are limited. The report notes: “The patient is extremely sensitive to pain, screams loudly with almost every needle movement, but does not abort the examination despite repeated reminders that she can stop the procedure at any time.” Despite this clear evidence of severe pain and cold sensitivity, the report fails to examine or contextualize these symptoms within the broader clinical assessment. This omission is...